MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cyt.70047

Медицинская библиотека · Cytopathology : official journal of the British Society for Clinical Cytology · 2025

Diagnostic Performance of EUS-FNA for Pancreatic Lesions at Tertiary Centers in Iran Without Rapid On-Site Evaluation.

Bazmandegan Maryam, Sivandzadeh Gholam Reza, Lankarani Kamran Bagheri, Beyzaei Zahra, Geramizadeh Bita

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is widely used for diagnosing pancreatic neoplasms, contributing to improved therapeutic strategies for pancreatic cancer. This aim of this study is to evaluate the diagnostic utility, sample adequacy, and limitations of EUS-FNA cytology for pancreatic lesions. These were further confirmed after surgical resection and histopathological evaluation.

METHODS

We retrospectively included patients referred to two Teaching Hospitals in southern Iran for EUS-FNA due to suspected pancreatic cancer, who later underwent surgical resection or biopsy and eventually had a histopathological confirmed diagnosis. The cytological smears from EUS-FNA were compared with the final histology reports to assess diagnostic performance.

RESULTS

Thirty patients were included in the final analysis. EUS-FNA cytology showed sensitivity of 90.00% [95% CI: 68.30, 98.77], specificity of 80.00% [95% CI: 44.39, 97.48], negative predictive value (NPV) of 80.00% [95% CI: 50.89, 93.92], positive predictive value (PPV) of 90.00% [95% CI: 72.09, 96.91], and overall accuracy of 86.67% [95% CI: 69.28, 96.24]. Two false-positive diagnoses (hydatid cyst and chronic pancreatitis) and two false-negative diagnoses (malignancies attributed to sampling errors) were observed. Immunohistochemical tests confirmed 8 out of 9 diagnoses made by cytology. Notably, all EUS-FNA samples provided adequate material for conclusive diagnosis.

CONCLUSION

These results support the high importance of the diagnostic performance of EUS-FNA on solid pancreatic lesions, even without Rapid On Site Evaluation (ROSE), given that the sample is of adequate size for testing. Despite a few false negative and false positive diagnoses, EUS-FNA should be considered the first-line diagnostic tool for pancreatic lesions assessment.

Для цитирования: Bazmandegan Maryam, Sivandzadeh Gholam Reza, Lankarani Kamran Bagheri, Beyzaei Zahra, Geramizadeh Bita. Diagnostic Performance of EUS-FNA for Pancreatic Lesions at Tertiary Centers in Iran Without Rapid On-Site Evaluation.. Cytopathology : official journal of the British Society for Clinical Cytology. 2025. DOI: 10.1111/cyt.70047.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.